Journal
ACTA PHARMACEUTICA SINICA B
Volume 9, Issue 2, Pages 335-350Publisher
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2019.01.003
Keywords
Reactive oxygen species; Cerebral ischemia-reperfusion injury; Stroke; Dual-antioxidant mechanism; Chalcones; Antioxidants; Oxidative stress; NRF2/ARE
Categories
Funding
- ZheJiang Province Natural Science Funding of China (China) [LQ18H280008, Y19B020043, LY17H160059]
- National Natural Science Foundation of China (China) [81803580]
- University Students in Zhejiang Science and Technology Innovation Projects (China) [2018R413004]
- National Undergraduate Training Programs for Innovation and Entrepreneurship (China) [201810343025]
- Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences
Ask authors/readers for more resources
Scavenging reactive oxygen species (ROS) by antioxidants is the important therapy to cerebral ischemia-reperfusion injury (CIRI) in stroke. The antioxidant with novel dual-antioxidant mechanism of directly scavenging ROS and indirectly through antioxidant pathway activation may be a promising CIRI therapeutic strategy. In our study, a series of chalcone analogues were designed and synthesized, and multiple potential chalcone analogues with dual antioxidant mechanisms were screened. Among these compounds, the most active 33 not only conferred cytoprotection of H2O2-induced oxidative damage in PC12 cells through scavenging free radicals directly and activating NRF2/ARE antioxidant pathway at the same time, but also played an important role against ischemia/reperfusion-related brain injury in animals. More importantly, in comparison with mono-antioxidant mechanism compounds, 33 exhibited higher cytoprotective and neuroprotective potential in vitro and in vivo. Overall, our findings showed compound 33 could emerge as a promising anti-ischemic stroke drug candidate and provided novel dual-antioxidant mechanism strategies and concepts for oxidative stress-related diseases treatment. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available